Renaissance Capital logo

RARX News

US IPO Weekly Recap: BlackLine soars but 5 IPOs struggle including year's largest offering

ZTO

Six IPOs raised $2.3 billion this past week, including the year's largest US offering, China's logistics giant ZTO Express. ZTO priced above the range and proceeded to drop 15% on its first day, highly unusual given its pricing premium, size and...read more

Ra Pharmaceuticals prices IPO at $13, within the range

Ra Pharmaceuticals logo

Ra Pharmaceuticals, which is developing small molecule therapies for rare immune disorders, raised $92 million by offering 7 million shares at $13, within the range of $12 to $14. Ra Pharmaceuticals plans to list on the Nasdaq under the symbol RARX. Credit...read more

US IPO Week Ahead: China's ZTO Express delivers largest IPO of 2016 in a 6-deal week

ZTO

Six companies are on the US IPO calendar to raise $2.2 billion in the week ahead, or $2.6 billion including a large SPAC. October is set to surpass September as the...read more

Rare blood disorder biotech Ra Pharmaceuticals sets terms for $75 million IPO

Ra Pharmaceuticals logo

Ra Pharmaceuticals, which is developing small molecule therapies targeting rare blood disorders, announced terms for its IPO on Monday. The Cambridge, MA-based company plans to raise $75 million by offering 5.8 million shares at a price range of $12 to $14....read more